American Fusion™ Inc. (OTCQB: AMFN) has moved its Texatron™ Fusion Engine™ program from prototype development into active testing, a transition that could mark a significant step toward commercial fusion energy. The Southlake, Texas-based company reported that repeatable pulsed magnetic-confinement tests have produced peak pressures of approximately 100,000 atmospheres, a result it is leveraging to advance its deuterium–helium-3 (D–³He) fusion work.
The company is pursuing a pulsed magnetic-compression architecture rather than conventional steady-state magnetic-confinement systems. Its 5 MW pre-production Texatron™ has progressed through testing at Texas Tech University, following Texas regulatory approval for the company’s research systems. American Fusion is also continuing development on 500 kW and 5 MW configurations, according to a recent update (https://ibn.fm/ITBKg).
Harbinger Research has updated its coverage of American Fusion, highlighting the transition into active testing, 100 pending U.S. patent applications, the company’s OTCQB listing, and potential future technical and commercial milestones. The equity research coverage coincides with the company’s technical progress and may draw increased investor attention to the fusion sector.
The news matters because fusion energy promises a near-limitless, low-carbon power source, but has historically been decades away from commercial viability. American Fusion’s D–³He approach, if successful, could offer advantages such as reduced neutron activation and potentially lower radioactive waste compared to conventional deuterium–tritium fusion. However, the company still faces substantial scientific and engineering hurdles, including sustaining fusion conditions and scaling the technology.
With 100,000 atmospheres of peak pressure now reported, American Fusion is working to characterize the combination of temperature, density, and other parameters needed for net energy gain. The involvement of Texas Tech University and state regulatory approval lends external validation to the company’s testing protocols. The 100 pending patent applications suggest an aggressive intellectual property strategy, which could be crucial for attracting partners and investors in a capital-intensive industry.
For investors, the OTCQB listing provides liquidity but also carries higher risk typical of early-stage technology ventures. Harbinger Research’s updated coverage may help inform investment decisions by outlining potential milestones. The latest news and updates relating to AMFN are available in the company’s newsroom at https://ibn.fm/AMFNAbout.
Overall, American Fusion’s move into active testing represents a concrete step in its development roadmap, but the ultimate test will be whether it can translate experimental pressures into sustained, net-positive fusion reactions. The coming months of testing and characterization will be closely watched by both the scientific community and investors.
